|
ZNF609 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.175570E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.721950E-02 |
| Normal-vs-Stage2 |
5.083600E-01 |
| Normal-vs-Stage3 |
6.332000E-01 |
| Normal-vs-Stage4 |
7.709800E-01 |
| Stage1-vs-Stage2 |
4.226400E-01 |
| Stage1-vs-Stage3 |
1.999210E-01 |
| Stage1-vs-Stage4 |
6.557000E-01 |
| Stage2-vs-Stage3 |
7.933600E-01 |
| Stage2-vs-Stage4 |
9.569800E-01 |
| Stage3-vs-Stage4 |
9.265000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.054010E-01 |
| Normal-vs-AfricanAmerican |
1.907170E-01 |
| Normal-vs-Asian |
1.125010E-01 |
| Caucasian-vs-AfricanAmerican |
9.481200E-01 |
| Caucasian-vs-Asian |
5.895200E-01 |
| AfricanAmerican-vs-Asian |
5.390600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.541660E-02 |
| Normal-vs-Female |
3.905000E-01 |
| Male-vs-Female |
4.439200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.025400E-01 |
| Normal-vs-Extreme_Weight |
2.559500E-03 |
| Normal-vs-Obese |
6.646600E-01 |
| Normal-vs-Extreme_Obese |
9.816400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.234800E-01 |
| Normal_Weight-vs-Obese |
3.529000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.209000E-01 |
| Extreme_Weight-vs-Obese |
1.043810E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.346600E-01 |
| Obese-vs-Extreme_Obese |
3.103200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.807600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.686400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.417200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.155300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.014600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.783700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.557790E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.041670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.630000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.664200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.624500E-02 |
| Normal-VS-Type2 PRCC |
1.424250E-02 |
| Normal-VS-KIRP CIMP |
1.870580E-01 |
| Normal-VS-Unclassified PRCC |
5.423800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.658200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.179600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.112200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.506300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.880090E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.199000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.038400E-03 |
| Normal-vs-N1 |
4.467400E-01 |
| Normal-vs-N2 |
7.313400E-01 |
| N0-vs-N1 |
1.368400E-02 |
| N0-vs-N2 |
4.419000E-01 |
| N1-vs-N2 |
8.233200E-01 |
|
|
